ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Radiopharm Theranostics Limited

Radiopharm Theranostics Limited (RADOB)

0,002
0,00
(0,00%)
Geschlossen 05 Juni 8:00AM

Radiopharm Theranostics Limited (RADOB) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,002
( - )
Gebot
0,002
Fragen
0,003
Volumen
1.342.883
0,002 Tagesbereich 0,003
0,002 52-Wochen-Bereich 0,01
Marktkapitalisierung
Handelsende
0,002
Handelsbeginn
0,003
Letzte Trade
561
@
0.002
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
AUD 2.704.247
Ausgegebene Aktien
3.544.216.160
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-1,1
Gewinn pro Aktie (EPS)
-0,02
Erlöse (LTM)
16,28M
Nettogewinn (LTM)
-46,58M

Über Radiopharm Theranostics Limited

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
Carlton, Australia
Gegründet
2026
Radiopharm Theranostics Limited is listed in the sector of the Australische Börse with ticker RADOB. The last closing price for Radiopharm Theranostics was AUD0,00. Over the last year, Radiopharm Theranostics shares have traded in a share price range of AUD 0,002 to AUD 0,01.

Radiopharm Theranostics currently has 3.544.216.160 shares in issue. The market capitalisation of Radiopharm Theranostics is AUD7,09 million. Radiopharm Theranostics has a price to earnings ratio (PE ratio) of -1.10.

RADOB Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.001-33.33333333330.0030.0030.00231443190.00261723DE
4-0.001-33.33333333330.0030.0030.00231443190.00261723DE
12-0.002-500.0040.0040.00215494550.00298657DE
26-0.006-750.0080.010.00217353250.00526954DE
52-0.006-750.0080.010.00217353250.00526954DE
156-0.006-750.0080.010.00217353250.00526954DE
260-0.006-750.0080.010.00217353250.00526954DE

RADOB - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics Limited share price?
The current share price of Radiopharm Theranostics Limited is AUD 0,002
How many Radiopharm Theranostics Limited shares are in issue?
Radiopharm Theranostics Limited has 3.544.216.160 shares in issue
What is the market cap of Radiopharm Theranostics Limited?
The market capitalisation of Radiopharm Theranostics Limited is AUD 7,09M
What is the 1 year trading range for Radiopharm Theranostics Limited share price?
Radiopharm Theranostics Limited has traded in the range of AUD 0,002 to AUD 0,01 during the past year
What is the PE ratio of Radiopharm Theranostics Limited?
The price to earnings ratio of Radiopharm Theranostics Limited is -1,1
What is the cash to sales ratio of Radiopharm Theranostics Limited?
The cash to sales ratio of Radiopharm Theranostics Limited is 4,57
What is the registered address of Radiopharm Theranostics Limited?
The registered address for Radiopharm Theranostics Limited is 62 Lygon Street, Carlton, Victoria, 3053
What is the Radiopharm Theranostics Limited website address?
The website address for Radiopharm Theranostics Limited is www.radiopharmtheranostics.com

RADOB Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen